Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 15, 2025 $20.00 Call had some of the highest implied ...

Alkermes (ALKS) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a ...

“No, the lake is the pool,” he said. For more information about this property, please contact Realtor Tracy Kermes of Howard Hanna Real Estate. Her contact info is below. Monthly ...

Alkermes plc (NASDAQ:ALKS), a $4.6 billion pharmaceutical company, has reported the unfortunate passing of its Chief Financial Officer, Iain M. Brown, on Sunday. Mr. Brown had been battling cancer and ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...